Cogent Biosciences to Participate in 3rd Annual Evercore ISI HealthCONx Virtual Conference
A live audio webcast may be accessed through the "Events" tab on the investor relations section of the Cogent website at: https://investors.cogentbio.com/events. A replay of the webcast will be available for 30 days following the event.
About Cogent Biosciences, Inc.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, pertaining to the Company's planned participation at an investor conference, which may include discussion of the Company's business and operations, projected cash runways; future product development plans; and upcoming results from clinical trials. The use of words such as, but not limited to, "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "project," "should," "target," "will," or "would" and similar words expressions are intended to identify forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, our clinical results and other future conditions. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. We may not actually achieve the forecasts disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Such forward-looking statements are subject to a number of material risks and uncertainties including but not limited to those set forth under the caption "Risk Factors" in Cogent's most recent Annual Report on Form 10-K filed with the
View original content to download multimedia:http://www.prnewswire.com/news-releases/cogent-biosciences-to-participate-in-3rd-annual-evercore-isi-healthconx-virtual-conference-301177976.html
Amanda Sellers, email@example.com, 301.332.5574